LFB Plasma Acquires ImmunoTek Bio Center in Greenacres to Establish Office in Florida

As part of its mission to establish a reliable and consistent supply of plasma to patients in the U.S., LFB Plasma recently finalized the acquisition of ImmunoTek Bio Center in Greenacres. LFB Plasma uses innovative technologies to provide plasma-derived and recombinant products to patients facing chronic and severe diseases in major therapeutic areas such as hemostasis, immunology, and intensive care.

“We are excited about our expansion into South Florida, and we look forward to a successful transition of the ImmunoTek center in Greenacres,” says Jose Antonio Moreno Toscano (pictured), LFB USA CEO. “We are thankful for the staff who has participated in the build-up of this center and are keeping all 23 employees there, providing each staff member the benefits of being part of our global biopharmaceutical company. Our extended plans include not only additional Florida plasma donation center locations, but expansion of centers into other states. We are particularly happy to be part of community growth and development and hope to make a long-term and sustainable economic impact at the local level. Ultimately, each donation of plasma has the potential to provide lifesaving treatment to those in need and we are forever grateful for each donation.”

LFB Plasma is part of LFB Group, which was formed in 1994 in France has established itself as one of the top European companies involved in developing innovative biotech medicines and treatments with 15 biological products in more than 30 countries.

ImmunoTek Bio Center has been managing its Greenaches center after constructing the facility in 2017. The company is among the fastest-growing independent plasma collection center operators in the United States by being leaders in developing a reliable plasma supply chain for biopharmaceutical companies.

“We are pleased to reach this first milestone in our cooperative partnership with LFB and are looking forward to a strong business alliance that increases access to lifesaving plasma,” says Jerome Parnell III, CEO & president of ImmunoTek.

You May Also Like
Holy Cross Hospital the Latest to Propose New Emergency Department in Broward

Plans are under review for an outpatient center and ER to be built on a property in Fort Lauderdale that’s owned by the hospital.

Read More
Haller Foundation Gifts Whopping $5.2 Million to Broward Health Foundation

The funds will go toward building two new labs at Broward Health Medical Center in Downtown Fort Lauderdale.

Read More
HCA Healthcare to Bring New Emergency Department to Hollywood

The Nashville-based company has one freestanding emergency department in Homestead and is planning another in Boca.

Read More
Holy Cross Health Launches Healing Heroes Program To Honor Healthcare Workers Who Provide Compassionate Care

Patients can now recognize exceptional care while supporting Holy Cross Health’s mission.

Read More
Other Posts
Fort Lauderdale Housing Market Sees Major Shifts in June 2025

Despite rising prices and inventory, days on market are decreasing significantly year over year.

Read More
Budget Heads Agree to Kill Business Rent Tax and Make Back-to-School Tax Holiday Permanent

Nearly $905 million in general revenue cuts come from repealing Florida’s business rent tax, a levy charged by no other state.

Read More
Fifth Third Bank Names Marty McAndrew Market President and Commercial Banking Head for Florida

In his new role, McAndrew will lead the middle market banking teams throughout the state.

Read More
NAMI Artful Minds Event Raises Over $45K to Support Mental Health Programs

The fundraising event showcased a lineup of local artists whose work explores the intersection of mental health and artistic expression.

Read More